Remove 2026 Remove Healthcare Remove Leads
article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

The four devices will be put through their paces in real-world healthcare settings via pilot projects in Norway, Belgium, Slovenia, Spain, and Germany. The project started on 1 October and is scheduled to complete in September 2026. The post Janssen leads effort to cut waste in digital health devices appeared first on.

Leads 124
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Oak Street has 169 locations across 21 states and expects to nearly double its size to 300 centers by 2026.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. Secondly, pressure on healthcare spending is leading to greater consolidation.

article thumbnail

NewAmsterdam Pharma enters merger deal with Frazier Lifesciences

Pharmaceutical Technology

The SPAC is sponsored by a Frazier Healthcare Partners affiliate. Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company.

Pharma 59
article thumbnail

Biologics – manufacturing trends in a modern facility

European Pharmaceutical Review

Liam Dunne, MSD Biotech Site Lead, explains that the site operates at the forefront of science and technology with 15,000L-scale, repeatable, robust manufacturing processes to produce highly sensitive monoclonal antibodies (mAbs). How does it do this? Since 2021, Liam Dunne is the site head of MSD Biotech in Dublin.

article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. The MFPs will be announced publicly in September 2024 and go into effect on January 1, 2026.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23 References.